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AbstrACt
background Early onset sepsis (EOS) is defined as onset 
of sepsis within 72 hours after birth. Leucocyte-endothelial 
interactions play a pivotal part in EOS pathophysiology. 
Endothelial cell adhesion molecules (CAMs) orchestrate 
these interactions and their soluble isoforms (sCAMs) 
are released into the vasculature by enzymes called 
sheddases.
Purpose This study was undertaken to explore further 
the pathophysiology of EOS and to investigate the potential 
of sCAM and their sheddases as potential biomarkers for 
EOS.
Methods Stored serum aliquots were used from 71 
Surinamese newborns suspected of EOS and 20 healthy 
newborns from an earlier study. Serum had been collected 
within 72 hours after birth and six (8.6%) newborns had 
a positive blood culture with gram-negative pathogens. 
Concentrations of sCAMs sP-selectin, sE-selectin, soluble 
vascular cell adhesion molecule-1 , intercellular adhesion 
molecule-1 and platelet and endothelial cell adhesion 
molecule-1, sheddases matrix metalloproteinase-9 (MMP-
9) and neutrophil elastase (NE) and sheddase antagonist 
tissue-inhibitor of metalloproteinases-1 (TIMP-1) were 
measured simultaneously with Luminex and ELISA.
results MMP-9 and TIMP-1 levels were measured 
in serum of n=91 newborns and sCAMs and NE levels 
in serum of n=80 newborns, respectively. We found no 
differences in median concentrations of sCAMs, MMP-9 
and TIMP-1 or NE between blood culture positive EOS, 
blood culture negative EOS and control groups at start of 
antibiotic treatment.
Conclusions Our data indicate that serum 
concentrations of sCAMs and their sheddases have no 
clinical utility as biomarkers for EOS.
trial registration number NCT02486783. Results
IntroduCtIon
Early onset sepsis (EOS) in newborns within 
72 hours after birth remains a clinical chal-
lenge with high morbidity and mortality.1–3 
The majority of global neonatal deaths due 
to EOS occur in developing countries.4 The 
diagnosis of EOS is complicated, resulting 
in late recognition or overtreatment of 
newborns with antibiotics. These dilemmas 
arise because the pathophysiology of EOS is 
poorly understood.
A hallmark of sepsis pathophysiology is 
endothelial cell activation followed by leuco-
cyte recruitment into tissues.5 The current 
model describes the occurrence of a shift in 
balance in Tie2 receptor ligands Angiopoi-
etin (Ang)-1 and Ang-2 affecting endothelial 
integrity and increased expression of endo-
thelial cell adhesion molecules (CAMs), in 
particular P-selectin, E-selectin, vascular cell 
adhesion molecule (VCAM-1) and intercel-
lular adhesion molecule (ICAM-1) to facilitate 
this recruitment.6 7 These endothelial CAMs 
orchestrate leucocyte rolling on, adhesion 
to and diapedesis across the endothelium.7 8 
Also, platelet and endothelial cell adhesion 
molecule (PECAM-1), expressed at endothe-
lial cell junctions has a function in facilitating 
paracellular transmigration of leucocytes 
across the endothelium.9 After intravenous 
administration of endotoxin in healthy adults 
What is already known on this topic?
 ► Recently, we established an association of the 
Angiopoietin (Ang)-1/Ang-2 disbalance with blood 
culture positive early onset sepsis (EOS) in newborns.
 ► The relationship between this Ang-1/Ang-2 disbal-
ance and serum levels of soluble isoforms of cell 
adhesion molecules (sCAMs) and their sheddases is 
unclear.
What this study hopes to add?
 ► The Ang-1/Ang-2 disbalance in blood culture pos-
itive EOS is not paralleled by increased levels of 
sCAMs and their sheddases.
 ► Levels of sCAMs and their sheddases are high af-
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as a sepsis model, peak concentrations of Ang-2 prelude 
the release of soluble isoforms of cell adhesion mole-
cules (sCAMs) into the systemic circulation.10 Endothe-
lial CAMs are released through ectodomain shedding 
by enzymes called sheddases, in particular matrix metal-
loproteinase-9 (MMP-9) and neutrophil elastase (NE), 
released from granules in neutrophils.7 11 Both MMP-9 
and NE prepare the extracellular matrix for transmi-
gration of leucocytes into inflammatory sites.12 MMP-9 
activity is balanced by sheddase antagonist tissue-inhib-
itor of metalloproteinases-1 (TIMP-1).12–14
Recently, we showed in a cohort of near term and 
term Surinamese newborns that a systemic disbalance 
in Ang-2/Ang-1 concentrations was associated with 
blood culture positive EOS.15 This study was undertaken 
to examine if this disbalance is paralleled by increased 
serum concentrations of sCAMs and sheddases in this 
cohort of newborns with EOS to explore further the 
pathophysiology of EOS. We hypothesised that sCAM 
and sheddases concentrations measured at start of antibi-
otic treatment for suspected EOS are higher in newborns 
with blood culture positive EOS than in healthy controls.
MAterIAls And Methods
study design, subjects and clinical protocol
For this study, we used a Surinamese cohort of 20 healthy 
newborns and 71 newborns with suspected EOS from an 
earlier reported study.15 All newborns were included after 
admission between 1 April 2015 and 31  May 2016 to the 
neonatal care facility of Academic Pediatric Center Suri-
name at the Academic Hospital Paramaribo in Suriname. 
Included were newborns with a gestational age equal 
to or above 34 weeks in whom antibiotics were started 
within the first 72 hours of life for suspected EOS. Suspi-
cion of EOS was based on the attending physicians deci-
sion to start antibiotic treatment. Informed consent was 
obtained from at least one parent for the use of residual 
serum and clinical information. The study protocol was 
made available on  clinicaltrials. gov (NCT02486783) and 
was approved by the Surinamese Medical Ethical Board 
(VG-021-14A) including permission of one parent.
The management of these patients was described 
before.15 In short, healthy control newborns and 
newborns suspected of EOS were included at start of 
antibiotic treatment within 72 hours after birth. At start 
of antibiotic treatment, blood was collected for sepa-
ration and storage of serum. Controls were newborns 
without signs of infection receiving blood draws for 
hyperbilirubinaemia (n=20). Newborns with suspected 
EOS receiving treatment with intravenous antibiotics 
were divided in two groups based on result from blood 
culturing: blood culture negative EOS (n=65) and blood 
culture positive EOS (n=6).
sample collection, preparation and analysis
In the previous study, serum had been collected from 
whole blood collected after insertion of a venous 
cannula in newborns suspected of EOS and after capil-
lary collection in controls.15 Frozen serum samples had 
been transported on dry ice to the Netherlands and 
aliquoted and frozen again on arrival. A stored aliquot 
was used for the measurement of sP-selectin, sE-se-
lectin, vascular cell adhesion molecule-1 (sVCAM-1), 
sICAM-1 and sPECAM-1 using the Human Magnetic 
Bead Adhesion 6-plex panel performance assay 
(LHC0016M, Thermo Scientific, Waltham, Massachu-
setts, USA) according to the manufacturer’s instruc-
tions. ELISA was used on the same aliquots for meas-
urement of NE (HK319-02, Hycult Biotech, Uden, 
The Netherlands), MMP-9 (Quantikine DMP900, R&D 
systems, Minneapolis, Minnesota, USA) and TIMP-1 
(Quantikine DTM100, R&D systems), each according 
to the manufacturers’ instructions. For each molecule, 
a standard curve was established via which concentra-
tions in neonatal serum were determined. Levels below 
or above the linear part of this standard curve were 
reported as the lowest or highest value of the standard 
curve, respectively. We measured intra-assay variation 
between plates used in the same assay by calculating 
coefficient of variation between levels of each molecule 
in samples from the same patient divided over those 
plates and accepted a maximum of 20%.
statistical analysis
A Kruskal-Wallis test with Dunn’s correction for multiple 
comparisons was used for analysis between the blood 
parameters and the three groups (blood culture positive 
EOS, blood culture negative EOS and control groups). 
<0.05 were considered statistically significant. All analyses 
were done using Prism V.7.0a (Graphpad Software, San 
Diego, California, USA).
results
Demographic variables of the whole study cohort (n=91) 
can be found in table 1 of Ref. 15. Of baseline charac-
teristics, birth weight, age at presentation (between 0 
and 72 hours after birth) and Apgar score at 5 min were 
distributed unevenly among the three groups (p<0.05). 
Blood culture results revealed that 6 of 70 newborns with 
suspected EOS (8.6%; 95% CI 1.9% to 15.3%) had a posi-
tive blood culture with gram-negative pathogens Klebsiella 
pneumoniae (n=2), Enterobacter cloacae (n=2) and Escherichia 
coli (n=2). One newborn had EOS due to a spontaneous 
bacterial peritonitis. For n=4 other newborns, cause of 
EOS was unknown, but they presented with neonatal 
jaundice (n=1), perinatal asphyxia (n=1), meconium 
aspiration (n=1) and hypoglycaemia (n=1).
serum concentrations of soluble endothelial cell adhesion 
molecules and their sheddases
Due to the limited amount of serum available, not all 
molecules could be measured in all samples. We were 
able to measure MMP-9 and TIMP-1 levels in serum of 
n=90 newborns and sCAMs and NE levels in serum of 
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n=80 newborns, respectively. We found no differences 
in median concentrations of sCAMs (figure 1), MMP-9 
and TIMP-1 (figure 2) or NE (figure 3) between blood 
culture positive EOS, blood culture negative EOS and 
control groups at start of antibiotic treatment within 
72 hours after birth.
dIsCussIon
In this study, we investigated whether sCAMs and their 
sheddases circulate at higher concentrations in near and 
at term newborns with blood culture positive EOS at start 
of antibiotic treatment. In contrast to our hypothesis, 
none of the molecules showed any difference in serum 
concentrations between blood culture positive EOS, 
blood culture negative EOS and controls within 72 hours 
after birth. Our data indicate that serum concentrations 
of sCAMs and their sheddases have neither clinical utility 
as biomarkers for EOS nor to guide the start of antibiotic 
treatment.
Previously, we found evidence for endothelial cell 
activation in blood culture positive EOS in the same 
newborns used for this study, represented by a disbalance 
in Ang-2/Ang-1 ratio.15 Since the current data demon-
strate that this disbalance was not paralleled by increased 
release of sCAM or sheddases in EOS, we conclude that 
endothelial CAM shedding is not or to a lesser extent 
involved in the pathophysiology of EOS. For interpreta-
tion of our data, we reviewed and summarised available 
data on sCAMs and sheddases in newborns with sepsis 
in online supplementary table 1.16–34 Comparison of our 
results with other existing data is complicated because 
of heterogenic makeup of chosen cohorts. Only one 
study reported a comparable cohort of near and at term 
newborns with suspected EOS within 72 hours after birth, 
in whom increased concentrations of sICAM-1 and NE 
were associated with blood culture positive EOS.19 Other 
earlier studies compared concentrations of sCAMs in 
heterogenic cohorts consisting of newborns with different 
gestational and postnatal ages, either having EOS (based 
on varying definitions) or sepsis after 72 hours after birth 
(ie, late onset sepsis). This variation in inclusion criteria 
is an important confounding factor in the interpretation 
of the observed concentrations in septic and healthy 
newborns. Overall, our results are in line with these 
studies that show that clinical utility of sCAMs and shed-
dases in EOS is very limited.
In an earlier review by our group, we pooled published 
data on sCAM concentrations in newborns.7 Soluble 
CAM concentrations in the current study corresponded 
well with concentrations discussed in our review and 
those established in earlier studies in uninfected 
healthy newborns with similar gestational and post-
natal age.7 23 24 29–32 However, MMP-9, TIMP-1 and NE 
concentrations were different and up to 4-fold, 2-fold 
and 10-fold higher, respectively, than those reported in 
earlier studies,17 18 21 22 25 30 which may have been due to 
other methods used (see limitations). Furthermore, our 
Figure 1 Circulating levels of endothelial adhesion 
molecules sP-selectin, sE-selectin, sVCAM-1, sICAM-1 
and sPECAM-1 in Surinamese newborns. (A) sP-selectin; 
(B) sE-selectin; (C) sVCAM-1; (D) sICAM-1; (E) sPECAM-1. 
Bars represent median values and error bars 95% CI. 
P<0.05 were considered statistically significant. EOS, early 
onset sepsis; sICAM-1, soluble intercellular adhesion 
molecule-1; sPECAM-1; soluble platelet and endothelial 
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earlier review and earlier data indicated that significant 
age-related discrepancies exist in sCAM concentrations 
between newborns, children and adults. As an example, 
in at term newborns, sVCAM-1 concentrations in the first 
postnatal week were almost twice the concentrations in 
healthy adults and equally high compared with septic 
adults, suggesting that sVCAM-1 concentrations start 
of high in early newborn life and then decrease with 
increasing age.7 31 In our study, concentrations of sCAMs 
and sheddases during the first 3 days of life in our study 
remained stable, which was in contrast with earlier work 
in healthy newborns showing that sE-selectin decreased 
and sICAM-1 and sVCAM-1 increased between day 1 and 
5 after birth, while sPECAM-1 levels did not change.29–32 
Even though some discrepancies with earlier reports 
exist, overall one can conclude that these and our data 
indicate that concentrations of sCAMs and sheddases 
measured within 72 hours after birth are high and do 
not discriminate between septic and healthy newborns, 
which limits their use as biomarkers for early identifica-
tion or exclusion of EOS.
Our and pre-existing data suggest that overall high 
sCAM and sheddase concentrations in newborns are the 
result of other perinatal factors than EOS. Several patho-
physiological processes may explain this premise. Birth 
may induce a ‘pro-adhesive’ state of the endothelium 
leading to increased endothelial CAMs expression on, 
and shedding from, its surface. Additionally, the increase 
in overall leucocyte numbers and inflammatory activa-
tion of subsets associated with human birth, which was 
shown to be positively associated with increased perinatal 
stress,35–37 may cause higher intensity of leucocyte-endo-
thelial interactions and subsequent increases endothelial 
CAMs shedding. Aberrant adhesion of activated leuco-
cytes to activated endothelium is associated with endothe-
lial dysfunction and increased vascular permeability.38 39 
Shedding of endothelial CAMs may then result in preven-
tion of aberrant leucocyte adhesion on two complemen-
tary levels, namely (1) to lower endothelial CAMs density 
to prevent adhesion or promote de-adhesion of already 
adhering leucocytes and (2) to release circulating sCAMs 
that act as ‘decoy receptors’ to capture leucocytes in the 
Figure 2 Circulating levels of MMP-9 and TIMP-1, and 
TIMP-1/MMP-9 ratios in Surinamese newborns. (A) MMP-9; 
(B) TIMP-1; (C) TIMP-1/MMP-9 ratios. Bars represent median 
values and error bars 95% CI. P<0.05 were considered 
statistically significant. EOS, early onset sepsis;  MMP-
9, matrix metalloproteinase-9; TIMP-1, tissue inhibitor of 
metalloproteinase. 
Figure 3 Circulating levels of neutrophil elastase in 
Surinamese newborns. Bars represent median values and 
error bars 95% CI. P<0.05 were considered statistically 
significant. EOS, early onset sepsis.  
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vasculature to limit leucocyte-endothelial interactions.7 10 
Whether this occurs in real life and what the contribution 
is to sCAM and sheddase concentrations in newborns 
remains unknown and could be studied in neonatal 
animal models.40–42
Our study has some limitations. First, sample size was 
relatively small. As a result, logistic regression analysis 
of other factors, such as maternal perinatal factors or 
method of birth, potentially influencing levels of sCAMs 
and sheddases, was precluded. Larger studies in countries 
such as Suriname, where the incidence of EOS is relatively 
high in comparison to Western countries,43 are neces-
sary and can contribute to better insight in the vascular 
pathophysiology of EOS. Second, the use of serum in our 
study may have caused release of stored pools of MMP-9, 
TIMP-1 and NE from disrupted leucocytes during the 
clotting process, which could have accounted for higher 
levels of these molecules than reported in earlier studies. 
Last, repeated freeze-thaw cycles may have affected 
quality of serum samples with regards to reproducibility 
of NE concentrations.
In conclusion, our data indicate that serum concen-
trations of sCAMs and sheddases are not higher in Suri-
namese newborns with EOS versus controls at start of 
antibiotic treatment. Although concentrations may still 
increase significantly more in newborns with EOS, other 
mechanisms, such as perinatal stress during birth, may 
drive overall high concentrations in all newborns which 
precludes discrimination between septic and healthy 
newborns.
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